Published in Am J Kidney Dis on December 01, 1991
The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus (2010) 1.21
Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study. Clin Exp Immunol (1994) 1.15
Relative value of serum C3 and C4 levels in predicting relapse in systemic lupus erythematosus. Am J Kidney Dis (1991) 0.88
Role of serum anti-C1q antibodies as a biomarker for nephritis activity in pediatric and adolescent Egyptian female patients with SLE. Expert Opin Med Diagn (2012) 0.86
Cell-bound complement biomarkers for systemic lupus erythematosus: from benchtop to bedside. Rheum Dis Clin North Am (2010) 0.78
The Usefulness of Endothelial Cell Adhesion Molecules and Anti-C1q Antibody in Monitoring Systemic Lupus Erythematosus Disease Activity. Int Sch Res Notices (2014) 0.75
Diagnostic value of serum complement C3 and C4 levels in Chinese patients with systemic lupus erythematosus. Clin Rheumatol (2015) 0.75
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med (2001) 17.24
Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med (1995) 5.50
On standard definitions: 33 years hence. Arch Dermatol (1997) 4.32
Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest (1983) 3.57
Thiazide diuretic monotherapy for hypertension: diuretic's dark side just got darker. Kidney Int (2007) 2.84
The highly effective use of topical zinc pyrithione in the treatment of psoriasis: a case report. Dermatol Online J (1997) 2.68
A proper role for organized medicine in a new era. Cleve Clin J Med (1997) 2.67
Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med (1998) 2.49
The nephrotic syndrome associated with secondary syphilis. An immune deposit disease. Am J Med (1970) 2.37
Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int (2001) 2.17
[Study on the antigenic relationships between the group O:54 and other groups O of Salmonella]. Ann Inst Pasteur (Paris) (1971) 2.05
Review of the overall experience of captopril in hypertension. Arch Intern Med (1984) 1.99
Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport. J Immunol (1996) 1.88
A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int (1999) 1.82
Transcriptional regulation of the tyrosine hydroxylase gene by glucocorticoid and cyclic AMP. Proc Natl Acad Sci U S A (1987) 1.81
The living donor in kidney transplantation. Ann Intern Med (1987) 1.81
Studies of the mechanism by which phosphate infusion lowers serum calcium concentration. J Clin Invest (1966) 1.81
Local infectious complications following large joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate. Arthritis Rheum (1991) 1.79
Interaction of rifampin and glucocorticoids. Adverse effect on renal allograft function. JAMA (1976) 1.77
Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology? Heart (2003) 1.76
Human cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction. J Immunol (1999) 1.74
Serum complement component levels in human glomerulonephritis. Ann Intern Med (1971) 1.70
Survival data for patients undergoing chronic intermittent hemodialysis. Ann Intern Med (1969) 1.58
Minimal change glomerulopathy associated with nonsteroidal antiinflammatory drugs. Am J Kidney Dis (1989) 1.55
[Plasmid localization of the genetic determinant of the atypical saccharose positive character in Salmonella]. Ann Microbiol (Paris) (1973) 1.53
Preservation of natural endothelial cytopathogenicity of cytomegalovirus by propagation in endothelial cells. Arch Virol (1991) 1.52
Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int (2001) 1.52
Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis (2000) 1.50
Use of the serum creatinine to estimate glomerular filtration rate in health and early diabetic nephropathy. Collaborative Study Group of Angiotensin Converting Enzyme Inhibition in Diabetic Nephropathy. Am J Kidney Dis (1990) 1.49
Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med (1980) 1.47
Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys. Am J Kidney Dis (1996) 1.47
Proximal tubular epithelial hyperplasia in patients with chronic glomerular proteinuria. Kidney Int (2000) 1.46
Bidirectional transmission of infectious cytomegalovirus between monocytes and vascular endothelial cells: an in vitro model. J Infect Dis (1995) 1.46
Complement depletion accelerates the clearance of immune complexes from the circulation of primates. J Clin Invest (1984) 1.46
Clinical evaluation of transtracheal Doppler for continuous cardiac output estimation. Anesth Analg (1992) 1.45
Eosinophilia in the diagnosis of atheroembolic renal disease. Am J Nephrol (1987) 1.44
Deficient IgA antibody responses to arsanilic acid bovine serum albumin (BSA) in neonatally thymectomized rabbits. J Immunol (1971) 1.43
Giardia sp. cysts and infectious Cryptosporidium parvum oocysts in the feces of migratory Canada geese (Branta canadensis). Appl Environ Microbiol (1998) 1.43
Development of antinuclear antibodies during acebutolol therapy. Clin Pharmacol Ther (1979) 1.42
Renal allograft survival following acute rejection correlates with blood pressure levels and histopathology. Kidney Int (1999) 1.42
Fish-oil-containing diet and platelet aggregation. Nutrition (1993) 1.42
[Dangers and meaning of fecal contamination of vegetable foods and feed in regard to the epidemiology of salmonelloses]. Arch Hyg Bakteriol (1967) 1.40
Every action causes a reaction: the inevitable backlash against managed care. Cleve Clin J Med (1997) 1.39
Renoprotective therapy: how good can it get? Kidney Int (2000) 1.39
Therapy of membranous nephropathy: what to do after the after (meta) analyses. J Am Soc Nephrol (1995) 1.39
Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group. Am J Kidney Dis (1999) 1.37
Regulation of tyrosine hydroxylase mRNA by glucocorticoid and cyclic AMP in a rat pheochromocytoma cell line. Isolation of a cDNA clone for tyrosine hydroxylase mRNA. J Biol Chem (1983) 1.37
Gamma G globulin subgroup composition of the glomerular deposits in human renal diseases. J Clin Invest (1970) 1.35
Importance of endothelial VCAM-1 for inflammatory leukocytic infiltration in vivo. J Immunol (1992) 1.34
Prevalence of Cryptosporidium, Giardia and Eimeria infections in post-weaned and adult cattle on three Maryland farms. Vet Parasitol (2000) 1.34
Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. The Collaborative Study Group. Nephrol Dial Transplant (1998) 1.34
In vitro evidence for cellular hypersensitivity to glomerular-basement-membrane antigens in human glomerulonephritis. N Engl J Med (1970) 1.33
Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients. Am J Kidney Dis (1999) 1.33
Quality of life in multiple sclerosis. Comparison with inflammatory bowel disease and rheumatoid arthritis. Arch Neurol (1992) 1.31
Suppressor cell function defect in idiopathic systemic lupus erythematosus. Clin Immunol Immunopathol (1979) 1.28
The importance of sample size in the interpretation of the renal biopsy. Am J Nephrol (1988) 1.27
CR1 and CR1-like: the primate immune adherence receptors. Immunol Rev (2001) 1.27
Survival of infectious Cryptosporidium parvum oocysts in seawater and eastern oysters (Crassostrea virginica) in the Chesapeake Bay. Appl Environ Microbiol (1998) 1.27
An immunopathologic study of rapidly progressive glomerulonephritis in the adult. Hum Pathol (1971) 1.27
Circulating anticoagulants to factor VIII. Immunochemical studies and clinical response to factor VIII concentrates. Am J Med (1970) 1.26
Pulmonary hemorrhage in systemic lupus erythematosus. Medicine (Baltimore) (1978) 1.25
Glomerular deposition of tumor antigen in membranous nephropathy associated with colonic carcinoma. Am J Med (1974) 1.24
Chronic autologous immune complex glomerulopathy: effect of cyproheptadine. J Lab Clin Med (1974) 1.24
Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology (1999) 1.23
Studies on the mechanisms of action of progesterone antagonists. J Steroid Biochem (1986) 1.22
Potential Role of the Eastern Oyster, Crassostrea virginica, in the Epidemiology of Cryptosporidium parvum. Appl Environ Microbiol (1997) 1.21
The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus (2010) 1.21
Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group. Kidney Int (1996) 1.20
Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares. Kidney Int (2007) 1.18
Renal artery dissection causing renal infarction in otherwise healthy men. Am J Kidney Dis (1997) 1.17
Experimental glomerulonephritis in the guinea pig. I. Glomerular lesions associated with antiglomerular basement membrane antibody deposits. Lab Invest (1973) 1.16
The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type 1 diabetic patients with nephropathy. The Collaborative Study Group. Am J Kidney Dis (1995) 1.12
Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli. J Clin Invest (1986) 1.11
Primary focal segmental glomerulosclerosis: clinical course and response to therapy. Am J Kidney Dis (1994) 1.11
On the antigenic relationship of "Vibrio cholerae" to "Enterobacteriaceae". Ann Inst Pasteur (Paris) (1972) 1.10
[Serological integration of all known Arizona-species into the Kauffmann-White-scheme (author's transl)]. Zentralbl Bakteriol Orig A (1979) 1.10
An economic analysis of captopril in the treatment of diabetic nephropathy. The Collaborative Study Group. Diabetes Care (1996) 1.10
Renal autoregulation and vulnerability to hypertensive injury in remnant kidney. Am J Physiol (1987) 1.10
5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol (2012) 1.10
Trans vivo analysis of human delayed-type hypersensitivity reactivity. Hum Immunol (1999) 1.09
Profuse fimbriae conferring O-inagglutinability to several strains of S. typhi-murium and S. enteritidis isolated from pasta products. Cultural, morphological, and serological experiments. Zentralbl Bakteriol Orig A (1975) 1.08
Focal segmental glomerular sclerosis: the cellular lesion. Kidney Int (1985) 1.07
Morphometric analysis of neointimal formation in murine cardiac allografts. Transplantation (1997) 1.07
Trans-synaptic increase in RNA coding for tyrosine hydroxylase in a rat sympathetic ganglion. Brain Res (1985) 1.07
The erythrocyte-immune complex-glomerulonephritis connection in man. Kidney Int (1987) 1.07
Health quality data: are flawed data better than none? Cleve Clin J Med (1997) 1.07
A homeodomain protein selectively expressed in noradrenergic tissue regulates transcription of neurotransmitter biosynthetic genes. J Neurosci (1995) 1.07
Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. Transplantation (1999) 1.06
Immunotactoid glomerulopathy. Medicine (Baltimore) (1985) 1.06
Weighted criteria for the diagnosis of systemic lupus erythematosus. Arch Intern Med (1984) 1.05
Some hemodynamic determinants of immune complex trapping by the kidney. Kidney Int (1978) 1.05
Clearance of human antibody/DNA immune complexes and free DNA from the circulation of the nonhuman primate. Clin Immunol Immunopathol (1987) 1.04
Eosinophilia as a clue to the diagnosis of atheroembolic renal disease. Arch Intern Med (1987) 1.04
Viral inhibition of interferon signal transduction. Intervirology (1999) 1.04
Identification of antinative DNA antibodies in cryoglobulinemic states. Am J Med (1978) 1.04
T lymphocyte activation by cytomegalovirus-infected, allogeneic cultured human endothelial cells. Transplantation (1992) 1.03
Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus. Cytogenet Genome Res (2009) 1.03
Accessory nipples and associated conditions. Pediatr Dermatol (1997) 1.03
Inducible expression of an endothelial cell antigen on murine myocardial vasculature in association with interstitial cellular infiltration. Transplantation (1989) 1.03